🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/07/2003 | 58,59 | 58,97 | 57,83 | 58,94 | +1,25% | 1,94% | 4.883.890 |
| 17/07/2003 | 58,90 | 59,45 | 57,89 | 58,22 | -1,17% | 2,64% | 4.388.081 |
| 16/07/2003 | 59,16 | 59,45 | 58,57 | 58,90 | -0,23% | 1,48% | 4.836.625 |
| 15/07/2003 | 59,54 | 59,82 | 58,49 | 59,04 | +0,19% | 2,23% | 5.805.186 |
| 14/07/2003 | 58,73 | 59,77 | 58,61 | 58,92 | +0,50% | 1,98% | 5.649.454 |
| 11/07/2003 | 58,11 | 58,66 | 57,79 | 58,63 | +0,66% | 1,51% | 4.104.911 |
| 10/07/2003 | 58,64 | 58,81 | 57,82 | 58,24 | -0,55% | 1,68% | 4.679.634 |
| 09/07/2003 | 58,84 | 59,37 | 58,13 | 58,57 | -0,45% | 2,11% | 5.780.768 |
| 08/07/2003 | 58,92 | 59,24 | 58,59 | 58,84 | -0,37% | 1,10% | 4.325.410 |
| 07/07/2003 | 58,21 | 59,51 | 58,21 | 59,06 | +1,23% | 2,25% | 6.010.490 |
| 03/07/2003 | 58,40 | 58,83 | 57,78 | 58,34 | -0,94% | 1,80% | 4.933.355 |
| 02/07/2003 | 59,19 | 59,64 | 58,89 | 58,89 | +0,41% | 1,26% | 8.408.314 |
| 01/07/2003 | 57,73 | 58,79 | 56,98 | 58,65 | +1,52% | 3,14% | 6.840.506 |
| 30/06/2003 | 58,30 | 58,67 | 57,54 | 57,78 | -0,77% | 1,95% | 5.798.060 |
| 27/06/2003 | 58,09 | 59,24 | 57,84 | 58,23 | -1,58% | 2,40% | 5.028.618 |
| 26/06/2003 | 57,85 | 59,35 | 57,82 | 59,16 | +1,34% | 2,64% | 5.394.056 |
| 25/06/2003 | 59,06 | 59,36 | 58,29 | 58,38 | -1,56% | 1,81% | 5.014.785 |
| 24/06/2003 | 58,44 | 59,69 | 58,43 | 59,30 | +0,06% | 2,17% | 6.449.706 |
| 23/06/2003 | 59,59 | 59,78 | 58,71 | 59,27 | -1,24% | 1,79% | 5.496.760 |
| 20/06/2003 | 59,45 | 60,35 | 59,35 | 60,01 | +0,95% | 1,69% | 7.822.167 |
| 19/06/2003 | 60,34 | 60,59 | 59,17 | 59,45 | -1,49% | 2,36% | 6.886.198 |
| 18/06/2003 | 59,33 | 60,55 | 59,00 | 60,34 | +1,39% | 2,62% | 13.435.779 |
| 17/06/2003 | 58,41 | 60,50 | 58,30 | 59,51 | +2,58% | 3,76% | 12.434.730 |
| 16/06/2003 | 56,52 | 58,51 | 56,50 | 58,02 | +2,65% | 3,56% | 11.450.029 |
| 13/06/2003 | 56,59 | 56,92 | 55,87 | 56,52 | -0,12% | 1,85% | 5.798.374 |
| 12/06/2003 | 56,77 | 57,01 | 56,19 | 56,58 | -0,05% | 1,45% | 5.093.280 |
| 11/06/2003 | 55,88 | 57,02 | 55,87 | 56,61 | +1,51% | 2,07% | 5.568.443 |
| 10/06/2003 | 55,61 | 55,92 | 54,96 | 55,77 | +0,26% | 1,72% | 4.363.662 |
| 09/06/2003 | 56,25 | 56,49 | 55,30 | 55,63 | -1,29% | 2,12% | 4.017.089 |
| 06/06/2003 | 56,52 | 57,50 | 55,82 | 56,36 | +0,53% | 2,97% | 8.809.174 |